We are live on ! Find out more
PHK

Point72 Hong Kong Portfolio holdings

AUM $2.18B
1-Year Est. Return 89.02%
This Fund
S&P 500
This Quarter Est. Return
+30.93%
1 Year Est. Return
+89.02%
3 Year Est. Return
+396.1%
5 Year Est. Return
+490.26%
10 Year Est. Return
+2,256.88%
AUM
$2.21B
AUM Growth
+$1.27B
Cap. Flow
+$1.02B
Cap. Flow %
46.14%
Top 10 Hldgs %
22.88%
Holding
2,190
New
1,023
Increased
285
Reduced
371
Closed
508

Top Buys

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$65M
2
WB icon
Weibo
WB
+$44.3M
3
JOYY
JOYY Inc
JOYY
+$24.5M
4
MNSO icon
MINISO
MNSO
+$20.6M
5
TCOM icon
Trip.com Group
TCOM
+$18.1M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$52.6M
2
HTHT icon
Huazhu Hotels Group
HTHT
+$46.1M
3
BILI icon
Bilibili
BILI
+$23.6M
4
EDU icon
New Oriental
EDU
+$18.8M
5
WYNN icon
Wynn Resorts
WYNN
+$12.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 12.64%
2 Technology 12.51%
3 Communication Services 8.36%
4 Healthcare 4.83%
5 Financials 4.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGNA
1626
DELISTED
TEGNA Inc
TGNA
$3K ﹤0.01%
222
-3,530
-94% -$47.2K
TROW icon
1627
T. Rowe Price
TROW
$24.3B
$3K ﹤0.01%
+21
New +$3K
TXMD icon
1628
TherapeuticsMD
TXMD
$24M
$3K ﹤0.01%
+50
New +$3.41K
WRAP icon
1629
Wrap Technologies
WRAP
$104M
$3K ﹤0.01%
+595
New +$3.45K
INFN
1630
DELISTED
Infinera Corporation Common Stock
INFN
$3K ﹤0.01%
303
-3,580
-92% -$28.4K
ROIC
1631
DELISTED
Retail Opportunity Investments Corp.
ROIC
$3K ﹤0.01%
+257
New +$3.15K
FUSN
1632
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$3K ﹤0.01%
+240
New +$3.02K
NVTA
1633
DELISTED
Invitae Corporation
NVTA
$3K ﹤0.01%
+76
New +$3.63K
AVID
1634
DELISTED
Avid Technology Inc
AVID
$3K ﹤0.01%
+202
New +$2.26K
TEN
1635
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$3K ﹤0.01%
+307
New +$2.9K
GLUU
1636
DELISTED
Glu Mobile Inc.
GLUU
$3K ﹤0.01%
332
-5,223
-94% -$45K
EIGI
1637
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$3K ﹤0.01%
+297
New +$2.46K
AXSM icon
1638
Axsome Therapeutics
AXSM
$10.9B
$2K ﹤0.01%
27
-475
-95% -$35.5K
STEX
1639
Streamex Corp
STEX
$83M
$2K ﹤0.01%
+50
New +$2.2K
DFIN icon
1640
Donnelley Financial Solutions
DFIN
$1.16B
$2K ﹤0.01%
+102
New +$1.58K
EIG icon
1641
Employers Holdings
EIG
$889M
$2K ﹤0.01%
57
-1,340
-96% -$43.3K
FFIC
1642
DELISTED
Flushing Financial
FFIC
$2K ﹤0.01%
+138
New +$1.91K
CBIO
1643
Crescent Biopharma
CBIO
$626M
$2K ﹤0.01%
+5
New +$1.75K
IGMS
1644
DELISTED
IGM Biosciences
IGMS
$2K ﹤0.01%
27
-60
-69% -$4.22K
KALA icon
1645
KALA BIO
KALA
$14.5M
0
MBIO icon
1646
Mustang Bio
MBIO
$4.55M
$2K ﹤0.01%
+1
New +$2.39K
LITS
1647
Lite Strategy Inc
LITS
$30.9M
$2K ﹤0.01%
+33
New +$1.9K
MLTX icon
1648
MoonLake Immunotherapeutics
MLTX
$1.55B
$2K ﹤0.01%
+188
New +$2K
NKTR icon
1649
Nektar Therapeutics
NKTR
$2.58B
$2K ﹤0.01%
+9
New +$2.33K
NX icon
1650
Quanex
NX
$1.01B
$2K ﹤0.01%
88
-62
-41% -$1.28K

Similar funds

Point72 Hong Kong's Q4 2020 Portfolio in Review

As of Q4 2020, Point72 Hong Kong held 2,190 positions worth $2.21B, up 135% from $942M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Point72 Hong Kong deployed $1.02B of net new capital in Q4 2020, opening 1,023 new positions and adding to 285 existing holdings. Its largest new stake was Pinduoduo: 543,655 shares worth $96.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, down from 23% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Alibaba, an estimated $52.6M trimmed.

  • Point72 Hong Kong's largest Q4 2020 buy was Pinduoduo: 543,655 shares worth $96.6M.
  • Point72 Hong Kong added most to Weibo in Q4 2020, an estimated $44.3M increase.
  • Point72 Hong Kong's biggest Q4 2020 reduction was Alibaba, cutting an estimated $52.6M.
  • Point72 Hong Kong fully exited Huazhu Hotels Group in Q4 2020, selling an estimated $46.1M.
  • Point72 Hong Kong's ten largest holdings make up 23% of its $2.21B portfolio in Q4 2020.
  • Point72 Hong Kong opened 1,023 new positions and closed 508 in Q4 2020.
  • Point72 Hong Kong's portfolio value rose 135% quarter-over-quarter to $2.21B.

Based on Point72 Hong Kong's 13F filing for Q4 2020, filed 16 Feb 2021.